164 results
Page 7 of 9
8-K
EX-99.1
0zd57 1tu9
11 Oct 06
Discovery Labs Announces Topline Results of Surfaxin® Phase 2 Clinical Trial for the Prevention and Treatment of BPD
12:00am
8-K
EX-99.1
fl0g1gm
5 Apr 06
Discovery Labs Receives Second Approvable Letter from FDA
12:00am
8-K
EX-99.1
i1ek8tj8yctkhb12
30 Jan 06
Other Events
12:00am
8-K
EX-10.1
iwxvc87gt9yz1
3 Jan 06
Represents strategic decision to control manufacturing of Surfaxinâ and SRT pipeline
12:00am
8-K
EX-99.1
hurtpqj3jx0
12 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
5adfb lj7yf9
21 Oct 05
FDA Accepts Discovery Labs’ Complete Response to
12:00am
8-K
EX-99.1
qgi52go97qdil2rnt0se
9 Sep 05
Discovery Labs Completes Pilot Phase 2 Study of Investigational Drug Aerosurf™, its Aerosolized Surfactant Delivered via Nasal CPAP
12:00am
8-K
EX-99.1
nf8rtg3q9acd2u
1 Aug 05
Discovery Labs Submits Response to FDA Approvable Letter for SurfaxinÒ for RDS in Premature Infants
12:00am